Hyperammonemia and Ornithine Transcarbamylase Deficiency after Bariatric Surgery: A Retrospective Study
dc.contributor.author | Pardo Lameda, Ivanesa L. | en |
dc.contributor.author | Wang, Eugene | en |
dc.contributor.author | Sharbaugh, Matthew | en |
dc.contributor.author | Lovette, Anyea | en |
dc.contributor.author | Shope, Timothy R. | en |
dc.contributor.author | Koch, Timothy R. | en |
dc.date.accessioned | 2024-12-02T15:01:18Z | en |
dc.date.available | 2024-12-02T15:01:18Z | en |
dc.date.issued | 2024-07-17 | en |
dc.description.abstract | Background: The number of bariatric surgeries has risen in the past decades. Hyperammonemia related to ornithine transcarbamylase (OTC) deficiency is a potentially lethal disorder in patients with neurological symptoms. The apparent prevalence of OTC deficiency and potential predictors of mortality was examined in patients after bariatric surgery. Methods: This is a retrospective study of postoperative patients who developed hyperammonemia in a large, urban teaching hospital. Urinary orotic acid levels were ordered in individuals with elevated plasma ammonia. Results: Between January 2012 and August 2017, 1597 bariatric surgical procedures were performed. Seven women hospitalized with consistent symptoms had a mean peak plasma ammonia level of 155 umol/L (range: 57 to 273) and mean urinary orotic acid excretion of 3.3 mmol/mol creatinine (range: 1.6–7.9) after vertical sleeve gastrectomy, duodenal switch, or gastric bypass surgery, and there were four mortalities (57%). The apparent postoperative prevalence of OTC deficiency is 0.31%. Peak lactic acid (p = 0.011) level is a predictor of mortality. Conclusions: Hyperammonemia is associated with a high mortality rate predicted by high lactic acid levels. Postoperative prevalence of OTC deficiency is higher than the general population. Further investigations should examine potential mechanisms for its development. | en |
dc.description.version | Accepted version | en |
dc.format.extent | 5 page(s) | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1089/bari.2023.0057 | en |
dc.identifier.eissn | 2168-0248 | en |
dc.identifier.issn | 2168-023X | en |
dc.identifier.orcid | Koch, Timothy [0000-0002-8026-9653] | en |
dc.identifier.uri | https://hdl.handle.net/10919/123669 | en |
dc.language.iso | en | en |
dc.publisher | Mary Ann Liebert | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject | ornithine carbamoyltransferase deficiency disease | en |
dc.subject | hyperammonemia | en |
dc.subject | bariatric surgery | en |
dc.subject | obesity | en |
dc.subject | gastric bypass | en |
dc.title | Hyperammonemia and Ornithine Transcarbamylase Deficiency after Bariatric Surgery: A Retrospective Study | en |
dc.title.serial | Bariatric Surgical Practice and Patient Care | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Article | en |
dc.type.other | Early Access | en |
dc.type.other | Journal | en |
pubs.organisational-group | Virginia Tech | en |
pubs.organisational-group | Virginia Tech/VT Carilion School of Medicine | en |
pubs.organisational-group | Virginia Tech/VT Carilion School of Medicine/Internal Medicine | en |
pubs.organisational-group | Virginia Tech/VT Carilion School of Medicine/Internal Medicine/General IM | en |